HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
+7.61%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$175M
AUM Growth
+$175M
(+5.7%)
Cap. Flow
+$6.43M
Cap. Flow
% of AUM
3.67%
Top 10 Holdings %
Top 10 Hldgs %
36.64%
Holding
129
New
19
Increased
30
Reduced
20
Closed
16
Top Buys
| 1 |
NLSN
Nielsen Holdings plc
NLSN
|
$3.17M |
| 2 |
BKI
Black Knight, Inc. Common Stock
BKI
|
$2.73M |
| 3 |
VMW
VMware, Inc
VMW
|
$2.51M |
| 4 |
Repare Therapeutics
RPTX
|
$1.84M |
| 5 |
Cogent Biosciences
COGT
|
$1.78M |
Top Sells
| 1 |
COHR
Coherent Inc
COHR
|
$3.62M |
| 2 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$2.96M |
| 3 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$2.37M |
| 4 |
IDEAYA Biosciences
IDYA
|
$1.8M |
| 5 |
Dyne Therapeutics
DYN
|
$1.77M |
Sector Composition
| 1 | Healthcare | 46.35% |
| 2 | Technology | 22.42% |
| 3 | Financials | 15.33% |
| 4 | Communication Services | 4.08% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Beam Therapeutics
BEAM
$1.66B
| $600K | 0.34% | 12,584 -8,396 | -40% | -$400K |
|
77
Enanta Pharmaceuticals
ENTA
$180M
| $585K | 0.33% | +11,286 | New | +$585K |
|
78
Amazon
AMZN
$2.44T
| $573K | 0.33% | 5,068 | – | – |
|
|
AMRN
79
Amarin Corp
AMRN
$311M
| $546K | 0.31% | 500,680 | – | – |
|
80
Vaxcyte
PCVX
$4B
| $501K | 0.29% | 20,870 -7,095 | -25% | -$170K |
|
|
MORF
81
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $498K | 0.28% | 17,601 -11,629 | -40% | -$329K |
|
82
Krystal Biotech
KRYS
$4.27B
| $490K | 0.28% | 7,035 -5,190 | -42% | -$361K |
|
|
RXDX
83
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $462K | 0.26% | 7,831 -2,951 | -27% | -$174K |
|
84
Terns Pharmaceuticals
TERN
$609M
| $456K | 0.26% | +77,344 | New | +$456K |
|
85
PTC
PTC
$25.6B
| $451K | 0.26% | 4,310 | – | – |
|
|
SWTX
86
DELISTED
SpringWorks Therapeutics
SWTX
| $368K | 0.21% | 12,888 -6,192 | -32% | -$177K |
|
87
T-Mobile US
TMUS
$284B
| $347K | 0.2% | 2,588 | – | – |
|
88
JD.com
JD
$44.1B
| $344K | 0.2% | 6,838 +1,740 | +34% | +$87.5K |
|
|
PNT
89
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $339K | 0.19% | +43,836 | New | +$339K |
|
90
Incyte
INCY
$16.5B
| $336K | 0.19% | +5,048 | New | +$336K |
|
91
Autodesk
ADSK
$67.3B
| $330K | 0.19% | 1,766 | – | – |
|
92
BioCryst Pharmaceuticals
BCRX
$1.74B
| $326K | 0.19% | +25,837 | New | +$326K |
|
|
IMGN
93
DELISTED
Immunogen Inc
IMGN
| $311K | 0.18% | 65,151 -126,575 | -66% | -$604K |
|
|
AVTA
94
DELISTED
Avantax, Inc. Common Stock
AVTA
| $307K | 0.18% | 15,872 | – | – |
|
95
Willis Towers Watson
WTW
$31.9B
| $296K | 0.17% | 1,474 | – | – |
|
96
Avidity Biosciences
RNA
$5.99B
| $283K | 0.16% | 17,334 -7,530 | -30% | -$123K |
|
97
PMV Pharmaceuticals
PMVP
$74.2M
| $278K | 0.16% | 23,324 | – | – |
|
98
ServiceNow
NOW
$190B
| $277K | 0.16% | 732 | – | – |
|
99
Autoliv
ALV
$9.53B
| $261K | 0.15% | 3,914 | – | – |
|
100
Warby Parker
WRBY
$3.2B
| $261K | 0.15% | 19,550 | – | – |
|